KIAA0895L_4931428F04Rik inhibitors belong to a class of chemical compounds that specifically target and inhibit the activity of the KIAA0895L protein, also referred to by its mouse ortholog 4931428F04Rik. The KIAA0895L gene encodes a protein that plays a role in various cellular processes, although its precise biological function remains under investigation. Inhibition of this protein can impact signaling pathways, protein-protein interactions, and downstream molecular effects within cells. These inhibitors are designed to selectively bind to KIAA0895L, reducing its activity and consequently modulating the cellular processes it regulates.
The chemical structures of KIAA0895L_4931428F04Rik inhibitors are characterized by distinct motifs that facilitate selective binding to their target. These inhibitors may vary in terms of their molecular backbone, stereochemistry, and functional groups, which influence their affinity, specificity, and mechanism of action against the KIAA0895L protein. Through biochemical assays, the activity of these inhibitors is often studied to understand their effects on cellular mechanisms such as transcriptional regulation, metabolic processes, or cell differentiation. The design of KIAA0895L inhibitors typically involves structure-based drug design principles, with structural biology and computational chemistry contributing to optimizing their binding properties. Thus, the molecular design of KIAA0895L_4931428F04Rik inhibitors emphasizes precision in targeting the protein's active or regulatory sites, ensuring effective modulation of its function in cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Stabilizes microtubules and prevents their disassembly, potentially altering MATCAP1 activity due to changes in microtubule dynamics. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
A microtubule-depolymerizing agent that disrupts microtubule networks, possibly affecting MATCAP1 by altering substrate availability. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $98.00 $315.00 $2244.00 $4396.00 $17850.00 $34068.00 | 3 | |
Binds tubulin, leading to microtubule depolymerization, potentially impacting MATCAP1 through modified microtubule dynamics. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $230.00 $450.00 $1715.00 $2900.00 | 4 | |
Disrupts microtubule assembly, possibly affecting MATCAP1 action by altering the microtubule structures it associates with. | ||||||
Podophyllotoxin | 518-28-5 | sc-204853 | 100 mg | $82.00 | 1 | |
Inhibits tubulin polymerization into microtubules, potentially affecting MATCAP1 by disrupting its microtubule-associated functions. | ||||||
Eribulin | 253128-41-5 | sc-507547 | 5 mg | $865.00 | ||
Inhibits the growth phase of microtubule dynamics, which could affect MATCAP1 by altering microtubule stability. | ||||||
Griseofulvin | 126-07-8 | sc-202171A sc-202171 sc-202171B | 5 mg 25 mg 100 mg | $83.00 $216.00 $586.00 | 4 | |
Disrupts microtubule function by binding to tubulin, potentially impacting MATCAP1 by interfering with microtubule-dependent processes. | ||||||
Docetaxel | 114977-28-5 | sc-201436 sc-201436A sc-201436B | 5 mg 25 mg 250 mg | $85.00 $325.00 $1072.00 | 16 | |
Promotes microtubule assembly and stabilizes microtubules, potentially affecting MATCAP1 through changes in microtubule dynamics. | ||||||
Laulimalide | 115268-43-4 | sc-507261 | 100 µg | $200.00 | ||
Binds to microtubules and stabilizes them, which could influence MATCAP1 activity due to altered microtubule structure. | ||||||